{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:24:31Z","timestamp":1791239071106,"version":"4.1.0"},"reference-count":81,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cellular Microbiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1111\/cmi.12590","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T20:59:59Z","timestamp":1458334799000},"page":"792-799","source":"Crossref","is-referenced-by-count":99,"title":["Cryptococcal therapies and drug targets: the old, the new and the promising"],"prefix":"10.1155","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-3031","authenticated-orcid":false,"given":"Carolina","family":"Coelho","sequence":"first","affiliation":[{"name":"Department of Molecular Microbiology and Immunology; Johns Hopkins Bloomberg School of Public Health, Baltimore; MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology; Johns Hopkins Bloomberg School of Public Health, Baltimore; MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"10.1111\/cmi.12590-BIB0001|cmi12590-cit-0001","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/EC.00103-15","article-title":"Virulence-associated enzymes of Cryptococcus neoformans","volume":"14","author":"Almeida","year":"2015","journal-title":"Eukaryot Cell"},{"key":"10.1111\/cmi.12590-BIB0002|cmi12590-cit-0002","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.mycmed.2014.04.004","article-title":"Anti-Candida and anti-Cryptococcus antifungal produced by marine microorganisms","volume":"24","author":"Amraoui","year":"2014","journal-title":"J Mycol Med"},{"key":"10.1111\/cmi.12590-BIB0003|cmi12590-cit-0003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ajcp\/25.1.14","article-title":"Tissue changes and tissue diagnosis in cryptococcosis; a study of 26 cases","volume":"25","author":"Baker","year":"1955","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/cmi.12590-BIB0004|cmi12590-cit-0004","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1586\/14787210.2014.856755","article-title":"Is there a role for statins in fungal infections?","volume":"11","author":"Bergman","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/cmi.12590-BIB0005|cmi12590-cit-0005","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1128\/IAI.67.7.3601-3609.1999","article-title":"Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates","volume":"67","author":"Blackstock","year":"1999","journal-title":"Infect Immun"},{"key":"10.1111\/cmi.12590-BIB0006|cmi12590-cit-0006","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.femsim.2004.05.001","article-title":"The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans","volume":"42","author":"Blasi","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1111\/cmi.12590-BIB0007|cmi12590-cit-0007","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/IAI.73.2.671-678.2005","article-title":"Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens","volume":"73","author":"Brady","year":"2005","journal-title":"Infect Immun"},{"key":"10.1111\/cmi.12590-BIB0008|cmi12590-cit-0008","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/21505594.2015.1038014","article-title":"Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes","volume":"6","author":"Brand\u00e3o","year":"2015","journal-title":"Virulence"},{"key":"10.1111\/cmi.12590-BIB0009|cmi12590-cit-0009","doi-asserted-by":"crossref","first-page":"e43582","DOI":"10.1371\/journal.pone.0043582","article-title":"Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative\/non-transplant","volume":"7","author":"Bratton","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/cmi.12590-BIB0010|cmi12590-cit-0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566524054022567","article-title":"Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans","volume":"5","author":"Casadevall","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1111\/cmi.12590-BIB0011|cmi12590-cit-0011","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1471-4906(03)00228-X","article-title":"Antibody-mediated regulation of cellular immunity and the inflammatory response","volume":"24","author":"Casadevall","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1111\/cmi.12590-BIB0012|cmi12590-cit-0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.2184","article-title":"A new synthesis for antibody-mediated immunity","volume":"13","author":"Casadevall","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1111\/cmi.12590-BIB0013|cmi12590-cit-0013","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/AAC.42.6.1437","article-title":"Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies","volume":"42","author":"Casadevall","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/cmi.12590-BIB0014|cmi12590-cit-0014","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/infdis\/165.6.1086","article-title":"Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection","volume":"165","author":"Casadevall","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0015|cmi12590-cit-0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11418-014-0884-2","article-title":"Antifungal activity of the essential oil of Angelica major against Candida, Cryptococcus, Aspergillus and dermatophyte species","volume":"69","author":"Cavaleiro","year":"2015","journal-title":"J Nat Med"},{"key":"10.1111\/cmi.12590-BIB0016|cmi12590-cit-0016","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/IAI.68.2.443-448.2000","article-title":"Urease as a virulence factor in experimental cryptococcosis","volume":"68","author":"Cox","year":"2000","journal-title":"Infect Immun"},{"key":"10.1111\/cmi.12590-BIB0080|cmi12590-cit-0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1534\/g3.112.004242","article-title":"Calcineurin governs thermotolerance and virulence of Cryptococcus gattii","volume":"3","author":"Chen","year":"2013","journal-title":"G3 (Bethesda)"},{"key":"10.1111\/cmi.12590-BIB0017|cmi12590-cit-0017","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/jam.12966","article-title":"Curcumin enhances the activity of fluconazole against Cryptococcus gattii-induced cryptococcosis infection in mice","volume":"120","author":"Silva","year":"2016","journal-title":"J Appl Microbiol"},{"key":"10.1111\/cmi.12590-BIB0018|cmi12590-cit-0018","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/j.semnuclmed.2008.10.007","article-title":"Radioimmunotherapy of infectious diseases","volume":"39","author":"Dadachova","year":"2009","journal-title":"Semin Nucl Med"},{"key":"10.1111\/cmi.12590-BIB0019|cmi12590-cit-0019","doi-asserted-by":"crossref","first-page":"10942","DOI":"10.1073\/pnas.1731272100","article-title":"Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection","volume":"100","author":"Dadachova","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/cmi.12590-BIB0020|cmi12590-cit-0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/AAC.31.5.834","article-title":"Activity of phenothiazines against medically important yeasts","volume":"31","author":"Eilam","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/cmi.12590-BIB0021|cmi12590-cit-0021","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1086\/317614","article-title":"The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans","volume":"182","author":"Feldmesser","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0022|cmi12590-cit-0022","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.41.2.331","article-title":"Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","volume":"41","author":"Franzot","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/cmi.12590-BIB0023|cmi12590-cit-0023","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2958.2010.07119.x","article-title":"KRE genes are required for beta-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformans","volume":"76","author":"Gilbert","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1111\/cmi.12590-BIB0024|cmi12590-cit-0024","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1086\/315649","article-title":"Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans","volume":"182","author":"Harrison","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0025|cmi12590-cit-0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3201\/eid1306.070154","article-title":"Invasive Cryptococcosis and adalimumab treatment","volume":"13","author":"Horcajada","year":"2007","journal-title":"Emerging Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0026|cmi12590-cit-0026","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02334-14","article-title":"Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritization","volume":"6","author":"Ianiri","year":"2015","journal-title":"MBio"},{"key":"10.1111\/cmi.12590-BIB0027|cmi12590-cit-0027","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0028|cmi12590-cit-0028","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"Jarvis","year":"2012","journal-title":"Aids"},{"key":"10.1111\/cmi.12590-BIB0029|cmi12590-cit-0029","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bmc.2014.12.006","article-title":"Design, synthesis, and biological evaluation of aminothiazole derivatives against the fungal pathogens Histoplasma capsulatum and Cryptococcus neoformans","volume":"23","author":"Khalil","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1111\/cmi.12590-BIB0030|cmi12590-cit-0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jac\/dkh522","article-title":"Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model","volume":"55","author":"Khan","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/cmi.12590-BIB0031|cmi12590-cit-0031","doi-asserted-by":"crossref","first-page":"36147","DOI":"10.1074\/jbc.M112.389676","article-title":"Cryptococcus neoformans activates RhoGTPase proteins followed by protein kinase C, focal adhesion kinase, and ezrin to promote traversal across the blood-brain barrier","volume":"287","author":"Kim","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1111\/cmi.12590-BIB0032|cmi12590-cit-0032","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1348-0421.2007.tb03963.x","article-title":"Adjuvant effect of CpG-oligodeoxynucleotide in anti-fungal chemotherapy against fatal infection with Cryptococcus neoformans in mice","volume":"51","author":"Kinjo","year":"2007","journal-title":"Microbiol Immunol"},{"key":"10.1111\/cmi.12590-BIB0033|cmi12590-cit-0033","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/JB.150.3.1414-1421.1982","article-title":"Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice","volume":"150","author":"Kwon-Chung","year":"1982","journal-title":"J Bacteriol"},{"key":"10.1111\/cmi.12590-BIB0034|cmi12590-cit-0034","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/cmi.12590-BIB0035|cmi12590-cit-0035","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1172\/JCI119688","article-title":"Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation","volume":"100","author":"Levitz","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1111\/cmi.12590-BIB0036|cmi12590-cit-0036","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tim.2009.06.006","article-title":"Color me bad: microbial pigments as virulence factors","volume":"17","author":"Liu","year":"2009","journal-title":"Trends Microbiol"},{"key":"10.1111\/cmi.12590-BIB0037|cmi12590-cit-0037","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1086\/317937","article-title":"Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus","volume":"183","author":"Lortholary","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0038|cmi12590-cit-0038","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1128\/IAI.67.12.6314-6320.1999","article-title":"Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection","volume":"67","author":"Lortholary","year":"1999","journal-title":"Infect Immun"},{"key":"10.1111\/cmi.12590-BIB0039|cmi12590-cit-0039","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/lam.12086","article-title":"Hydroxyaldimines as potent in vitro anticryptococcal agents","volume":"57","author":"Magalh\u00e3es","year":"2013","journal-title":"Lett Appl Microbiol"},{"key":"10.1111\/cmi.12590-BIB0040|cmi12590-cit-0040","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/AAC.49.7.2851-2856.2005","article-title":"Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins","volume":"49","author":"Maligie","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/cmi.12590-BIB0041|cmi12590-cit-0041","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/j.1462-5822.2012.01819.x","article-title":"Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier","volume":"14","author":"Maruvada","year":"2012","journal-title":"Cell Microbiol"},{"key":"10.1111\/cmi.12590-BIB0043|cmi12590-cit-0043","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1172\/JCI38322","article-title":"Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism","volume":"120","author":"McClelland","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/cmi.12590-BIB0044|cmi12590-cit-0044","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/13693780701390140","article-title":"Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients","volume":"45","author":"Meletiadis","year":"2007","journal-title":"Med Mycol"},{"key":"10.1111\/cmi.12590-BIB0045|cmi12590-cit-0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/426828","article-title":"Influence of indinavir on virulence and growth of Cryptococcus neoformans","volume":"191","author":"Monari","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0046|cmi12590-cit-0046","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/fgbi.1998.1052","article-title":"Melanin synthesis is associated with changes in hyphopodial turgor, permeability, and wall rigidity in gaeumannomyces graminis var. graminis","volume":"24","author":"Money","year":"1998","journal-title":"Fungal Genet Biol"},{"key":"10.1111\/cmi.12590-BIB0047|cmi12590-cit-0047","doi-asserted-by":"crossref","first-page":"e00647","DOI":"10.1128\/mBio.00647-15","article-title":"Identification of a new class of antifungals targeting the synthesis of fungal sphingolipids","volume":"6","author":"Mor","year":"2015","journal-title":"MBio"},{"key":"10.1111\/cmi.12590-BIB0048|cmi12590-cit-0048","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/j.ijid.2010.09.006","article-title":"Cryptococcal immune reconstitution syndrome during steroid withdrawal treated with hydroxychloroquine","volume":"15","author":"Narayanan","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0049|cmi12590-cit-0049","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/425121","article-title":"Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy","volume":"39","author":"Netea","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0050|cmi12590-cit-0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fmicb.2011.00212","article-title":"Fungal glucosylceramides: from structural components to biologically active targets of new antimicrobials","volume":"2","author":"Nimrichter","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1111\/cmi.12590-BIB0051|cmi12590-cit-0051","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diagmicrobio.2004.08.013","article-title":"Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies","volume":"51","author":"Nooney","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0052|cmi12590-cit-0052","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1128\/AAC.00545-06","article-title":"Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds","volume":"50","author":"Nosanchuk","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/cmi.12590-BIB0053|cmi12590-cit-0053","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/319272","article-title":"Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection","volume":"183","author":"Nosanchuk","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0054|cmi12590-cit-0054","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0002-9440(10)63734-0","article-title":"Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion","volume":"164","author":"Olszewski","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1111\/cmi.12590-BIB0055|cmi12590-cit-0055","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"Pappas","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0056|cmi12590-cit-0056","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"Aids"},{"key":"10.1111\/cmi.12590-BIB0057|cmi12590-cit-0057","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1054\/drup.1999.0090","article-title":"Drug resistance in Cryptococcus neoformans","volume":"2","author":"Perfect","year":"1999","journal-title":"Drug Resist Updat"},{"key":"10.1111\/cmi.12590-BIB0058|cmi12590-cit-0058","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0059|cmi12590-cit-0059","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/JCM.00618-09","article-title":"Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/cmi.12590-BIB0060|cmi12590-cit-0060","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect Immun"},{"key":"10.1111\/cmi.12590-BIB0061|cmi12590-cit-0061","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1365-2958.2006.05551.x","article-title":"Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence","volume":"63","author":"Reese","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1111\/cmi.12590-BIB0082|cmi12590-cit-0082","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","author":"Rhein","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0062|cmi12590-cit-0062","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/EC.00370-07","article-title":"Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence","volume":"7","author":"Rodrigues","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1111\/cmi.12590-BIB0063|cmi12590-cit-0063","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/EC.00318-06","article-title":"Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport","volume":"6","author":"Rodrigues","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1111\/cmi.12590-BIB0064|cmi12590-cit-0064","doi-asserted-by":"crossref","first-page":"e00573","DOI":"10.1128\/mBio.00573-13","article-title":"Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease","volume":"4","author":"Rohatgi","year":"2013","journal-title":"MBio"},{"key":"10.1111\/cmi.12590-BIB0065|cmi12590-cit-0065","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/IAI.69.5.3410-3412.2001","article-title":"Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection","volume":"69","author":"Rosas","year":"2001","journal-title":"Infect Immun"},{"key":"10.1111\/cmi.12590-BIB0066|cmi12590-cit-0066","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"MBio"},{"key":"10.1111\/cmi.12590-BIB0067|cmi12590-cit-0067","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/ajt.13002","article-title":"Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient","volume":"15","author":"Scemla","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/cmi.12590-BIB0068|cmi12590-cit-0068","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/IAI.70.5.2598-2604.2002","article-title":"Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3","volume":"70","author":"Shapiro","year":"2002","journal-title":"Infect Immun"},{"key":"10.1111\/cmi.12590-BIB0081|cmi12590-cit-0081","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality","volume":"195","author":"Singh","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0069|cmi12590-cit-0069","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/AAC.00694-13","article-title":"Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment","volume":"57","author":"Sionov","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/cmi.12590-BIB0070|cmi12590-cit-0070","doi-asserted-by":"crossref","first-page":"e1005040","DOI":"10.1371\/journal.ppat.1005040","article-title":"Type I IFN induction via poly-ICLC protects mice against cryptococcosis","volume":"11","author":"Sionov","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1111\/cmi.12590-BIB0071|cmi12590-cit-0071","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/649553","article-title":"Treatment of HIV-related inflammatory cerebral cryptococcoma with adalimumab","volume":"50","author":"Sitapati","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/cmi.12590-BIB0079|cmi12590-cit-0079","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrmicro1680","article-title":"Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections","volume":"5","author":"Steinbach","year":"2007","journal-title":"Nat Rev Micro"},{"key":"10.1111\/cmi.12590-BIB0072|cmi12590-cit-0072","article-title":"Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays","author":"Trevi\u00f1o-Rangel","year":"2015","journal-title":"Med Mycol"},{"key":"10.1111\/cmi.12590-BIB0073|cmi12590-cit-0073","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/1744666X.2014.908706","article-title":"The potential of radioimmunotherapy as a new hope for HIV patients","volume":"10","author":"Tsukrov","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1111\/cmi.12590-BIB0074|cmi12590-cit-0074","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1128\/AAC.46.11.3394-3400.2002","article-title":"Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin","volume":"46","author":"Duin","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/cmi.12590-BIB0075|cmi12590-cit-0075","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2217\/fmb.13.84","article-title":"Elucidating the immunological function of the Cryptococcus neoformans capsule","volume":"8","author":"Vecchiarelli","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1111\/cmi.12590-BIB0076|cmi12590-cit-0076","doi-asserted-by":"crossref","first-page":"e01101","DOI":"10.1128\/mBio.01101-14","article-title":"Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease","volume":"5","author":"Vu","year":"2014","journal-title":"MBio"},{"key":"10.1111\/cmi.12590-BIB0077|cmi12590-cit-0077","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/AAC.40.3.541","article-title":"Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine","volume":"40","author":"Wang","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/cmi.12590-BIB0078|cmi12590-cit-0078","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Cellular Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcmi.12590","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/cmi.12590\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T01:03:20Z","timestamp":1643331800000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cmi.12590"}},"subtitle":["Cryptococcal therapies and drug targets"],"short-title":[],"issued":{"date-parts":[[2016,4,8]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1111\/cmi.12590","archive":["Portico"],"relation":{},"ISSN":["1462-5814"],"issn-type":[{"value":"1462-5814","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,8]]}}}